ADCT

ADC Therapeutics SA

CIK 0001771910 · NYSE

NYSEHealth CarePharmaceutical Preparations

$1.00

↑ 0.04 (3.80%)

as of Aug 21, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 3/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap

$127.23M

P/E Ratio

-1.31

EPS

-1.12

Dividend Yield

Not covered

52W Position

Beta

1.33

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

-0.56

P/S

1.60

EV/Revenue

-1.08

ROE

42.5%

Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 5%

$0.78$4.98

Latest Financials

2025-12-31 FY

Revenue

$81.36M

Net Income

-$142.62M

Total Assets

$323.15M

Free Cash Flow

-$141.44M

ADCT

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

ADCT

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news